每两个月注射一次阿立哌唑（Abilify Asimtufii®）治疗双相情感障碍 I 型患者：通俗易懂的出版物摘要。

IF 3.4 3区医学 Q2 PHARMACOLOGY & PHARMACY

Therapeutic Advances in Psychopharmacology Pub Date : 2024-10-27 eCollection Date: 2024-01-01 DOI:10.1177/20451253241278830

Roger S McIntyre, Pedro Such, Murat Yildirim, Jessica Madera-McDonough, Na Jin, Suzanne Watkin, Zhen Zhang, Frank Larsen, Matthew Harlin

{"title":"每两个月注射一次阿立哌唑（Abilify Asimtufii®）治疗双相情感障碍 I 型患者：通俗易懂的出版物摘要。","authors":"Roger S McIntyre, Pedro Such, Murat Yildirim, Jessica Madera-McDonough, Na Jin, Suzanne Watkin, Zhen Zhang, Frank Larsen, Matthew Harlin","doi":"10.1177/20451253241278830","DOIUrl":null,"url":null,"abstract":"The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formulation of aripiprazole, given as an injection once every 2 months, with a once‑monthly injection of aripiprazole.","PeriodicalId":23127,"journal":{"name":"Therapeutic Advances in Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514105/pdf/","citationCount":"0","resultStr":"{\"title\":\"Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication.\",\"authors\":\"Roger S McIntyre, Pedro Such, Murat Yildirim, Jessica Madera-McDonough, Na Jin, Suzanne Watkin, Zhen Zhang, Frank Larsen, Matthew Harlin\",\"doi\":\"10.1177/20451253241278830\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formulation of aripiprazole, given as an injection once every 2 months, with a once‑monthly injection of aripiprazole.\",\"PeriodicalId\":23127,\"journal\":{\"name\":\"Therapeutic Advances in Psychopharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-10-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514105/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/20451253241278830\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20451253241278830","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

本摘要旨在解释一项包括双相情感障碍I患者在内的研究的主要结果，两项研究分别在两篇文章中进行了介绍（详情请参见 "更多信息 "部分）。该研究比较了每两个月注射一次的阿立哌唑新配方和每月注射一次的阿立哌唑。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii^®) in people with bipolar I disorder: a Plain Language Summary of Publication.

The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formulation of aripiprazole, given as an injection once every 2 months, with a once‑monthly injection of aripiprazole.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Therapeutic Advances in Psychopharmacology Multiple-

CiteScore

7.90

自引率

2.40%

发文量

审稿时长

10 weeks

期刊介绍： Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in psychopharmacology, providing a forum in print and online for publishing the highest quality articles in this area.